Therefore, in the present study, we investigated a panel of 6 well-studied polymorphisms in ESR1, ESR2 and PGR genes in a case–control design involving 410 GBC patients, 230 gallstone patients and 220 cancer/gallstone-free controls from North India. The gene discussed is PGR; the disease is cancer.